Ronald C. Newbold
2008
In 2008, Ronald C. Newbold earned a total compensation of $538.9K as Senior Vice President, Business Development at Celldex Therapeutics.
Compensation breakdown
| Bonus | $62,500 |
|---|---|
| Option Awards | $172,237 |
| Salary | $250,000 |
| Stock Awards | $50,000 |
| Other | $4,134 |
| Total | $538,871 |
Newbold received $250K in salary, accounting for 46% of the total pay in 2008.
Newbold also received $62.5K in bonus, $172.2K in option awards, $50K in stock awards and $4.1K in other compensation.
Rankings
In 2008, Ronald C. Newbold's compensation ranked 6,282nd out of 9,135 executives tracked by ExecPay. In other words, Newbold earned more than 31.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,282 out of 9,135 | 31st |
Division Manufacturing | 2,320 out of 3,436 | 33rd |
Major group Chemicals And Allied Products | 507 out of 815 | 38th |
Industry group Drugs | 342 out of 597 | 43rd |
Industry In Vitro and In Vivo Diagnostic Substances | 24 out of 51 | 53rd |
Source: SEC filing on November 6, 2009.
Newbold's colleagues
We found five more compensation records of executives who worked with Ronald C. Newbold at Celldex Therapeutics in 2008.
2008
Una Ryan
Celldex Therapeutics
Chief Executive Officer
2008
Anthony Marucci
Celldex Therapeutics
Chief Executive Officer
2008
Tibor Keler
Celldex Therapeutics
Chief Scientific Officer
2008
Avery Catlin
Celldex Therapeutics
Chief Financial Officer
2008
Thomas Davis
Celldex Therapeutics